John Fisher

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation <i>in vitro</i>

John Fisher, Michael J. Rogers, J. M. Halasy et al. · Proceedings of the National Academy of Sciences · 1999 · 679 citations

Medicine, Biochemistry, Pharmacology +17

The effect of nano- and micron-sized particles of cobalt–chromium alloy on human fibroblasts in vitro

Iraklis Papageorgiou, Christopher Brown, Roel P. F. Schins et al. · Biomaterials · 2007 · 381 citations

Natural Sciences, Biomedical Engineering, Materials Science +12

The Influence of Loading Time and Lubricant on the Friction of Articular Cartilage

H. Forster, John Fisher · Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine · 1996 · 379 citations

Medicine, Orthopedic Surgery, Biomechanics +16

Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in Vivo and in Vitro

Noboru Horiuchi, Michael P. Caulfield, John Fisher et al. · Science · 1987 · 358 citations

Medicine, Biochemistry, Endocrinology +17

M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase

Helmut Glantschnig, John Fisher, Gregg Wesolowski et al. · Cell Death and Differentiation · 2003 · 353 citations

Medicine, Cell Biology, Cell Signaling +13